38
Views
2
CrossRef citations to date
0
Altmetric
Original Article

Tuberculosis screening: A review and a potential role for prehospital care providers

&
Pages 47-53 | Received 31 Aug 1998, Accepted 01 Sep 1998, Published online: 02 Jul 2009

References

  • Wolinsky E. Tuberculosis. In: Baum GL, Wolinsky E (eds). Text-book of Pulmonary Diseases. Boston: Little, Brown and Com-pany, 1989, pp 465–519.
  • Centers for Disease Control. National action plan to combat mul-tidrug-resistant tuberculosis. MMWR. 1992;41(RR-11):5–48.
  • Farzan S. A Concise Handbook of Respiratory Diseases. Nor-walk, CT: Appleton St Lange, 1997.
  • Centers for Disease Control. Summary of notifiable diseases, United States 1992. MMWR. 1993;41:67.
  • Dooley SW, Jarvis WR, Martone WJ, Snider DE. Multidrug-resistant tuberculosis. Ann Intern Med. 1992;117:257–9.
  • Fischl MA, Uttamchandani RB, Daikos GL, et al. An outbreak of tuberculosis caused by multiple-drug-resistant tubercle bacilli among patients with HIV infection. Ann Intern Med. 1992;117: 177–83.
  • Centers for Disease Control. Nosocomial transmission of mul-tidrug-resistant tuberculosis among HIV-infected persons-Florida and New York, 1988-1991. MMWR. 1991;40:585–91.
  • Huebner RE, Villarino ME, Snider DE. Tuberculin skin testing and the HIV epidemic. JAMA. 1992;267:409–10.
  • Brudney K, Dabkin J. Resurgent tuberculosis in New York City. Am Rev Respir Dis. 1991;144:745–9.
  • Lynch JP, Toews GB. Fungal, mycobacterial, and viral pul-monary infections. In: Khan MG, Lynch JP (eds). Pulmonary Dis-ease Diagnosis and Therapy A Practical Approach. Baltimore: Williams & Wilkins, 1997, pp 401–10.
  • Centers for Disease Control and Prevention. Screening for tu-berculosis and tuberculosis infection in high-risk populations: recommendations of the Advisory Council for the Elimination of Tuberculosis. MMWR. 1995;44(RR-11):19–34.
  • Moffitt MP, Wisinger DB. Tuberculosis: recommendations for screening, prevention, and treatment. Postgrad Med. 1996;100: 201–20.
  • Centers for Disease Control and Prevention. Tuberculosis mor-bidity-United States, 1994. MMWR. 1995;44:387-9,395.
  • Centers for Disease Control and Prevention. Tuberculosis mor-bidity-United States 1993. MMWR. 1994;43:361–6.
  • Plorde JJ. Mycobacteria. In: Ryan KJ (ed). Sherris Medical Mi-crobiology. Norwalk, CT: Appleton & Lange, 1994, pp 401–16.
  • Graham NM, Galai N, Nelson NE, et al. Effect of isoniazid chemoprophylaxis on HIV-related mycobacterial disease. Arch Intern Med. 1996;156:889–94.
  • Pape JW, Jean SS, Ho JL, et al. Effect of isoniazid prophylaxis on incidence of active tuberculosis and progression of HIV infec-tion. Lancet. 1993;342:268–72.
  • U.S. Preventive Services Task Force. Guide to Clinical Preventive Services, 2nd ed. Alexandria, VA: International Medical Pub-lishing, 1996.
  • Centers for Disease Control and Prevention. Tuberculosis statis-tics in the United States, 1990. Atlanta: CDC, 1992.
  • Centers for Disease Control. Management of persons exposed to multidrug resistant tuberculosis. MMWR. 1992;41(RR-11):61–71.
  • Bloch AB, Cauthen GM, Onora to IM, et al. Nationwide survey of drug-resistant tuberculosis in the United States. JAMA. 1994;271: 665–71.
  • Centers for Disease Control and Prevention. Tuberculosis con-trol laws-United States, 1993. MMWR. / 993;42(RR-15):1–28.
  • Centers for Disease Control. A strategic plan for the elimination of tuberculosis in the United States. MMWR. 1989;38(S–3):269–72.
  • Hadler JL. Control of tuberculosis. In: Friedman LN (ed). Tuber-culosis Current Concepts and Treatment. Boca Raton, FL: CRC Press, 1994, pp 307–33.
  • Iseman MD, Cohn DL, Sbarbaro JA. Directly observed treatment of tuberculosis. N Engl J Med. 1993;328:576–8.
  • Chaulk CP, Moore-Rice K, Rizzo R, Chaisson RE. Eleven years of community-based directly observed therapy for tuberculosis. JAMA. 1995;274:945–51.
  • Centers for Disease Control. Screening for tuberculosis and tu-berculous infection in high-risk populations: recommendations of the Advisory Committee for the Elimination of Tuberculosis. MMWR. 1990;39(RR-8):1–7.
  • Sherer J. Bringing providers to the people. Hosp Health Netw. 1994;68:56–60.
  • Shoup S. Red River Project: expanded scope program for New Mexico medics. J Emerg Med Serv. 1995;20(12):43–7.
  • De Lorenzo RA. Military medic: the original expanded-scope EMS provider. J Emerg Med Serv. 1996;21(4):50–4.
  • Stanford TM. Civilian vs. military EMS. Emergency. 1988;20: 34–8.
  • Lutwick LI. Tuberculin skin testing. In: Lutwick LI (ed). Tuber-culosis. London: Chapman & Hall Medical, 1995.
  • Landi S, Held HR. Effect of light on tuberculin purified protein derivative solutions. Am Rev Respir Dis. 1975;111:52–61.
  • Rhoades ER, Bryant RE. The influence of local factors on the re-action to tuberculin. The effect of injection. Chest. 1980;77:190–3.
  • Victoria MS, Steiner P. Rao M. The effect of intradermal and sub- cutaneous route of administration variation in PPD sensitivity. Clin Pediatr. 1977;16:514–5.
  • Sokal JE. Measurement of delayed skin test response. N Engl J Med. 1975;293:501–2.
  • Jordan TJ, Sunderman G, Thomas L, et at. Tuberculin reaction size measurement by the pen method compared to traditional palpation. Chest. 1987;92:234–6.
  • Siebert AF, Bass JB. Tuberculin skin testing: guidelines for the 1990s. J Respir Dis. 1990;11:225–34.
  • Starke JR. Tuberculosis skin testing: new schools of thought. Pe-diatrics. 1996;98:123–5.
  • Starke JR, Jacobs RF, Jereb J. Resurgence of tuberculosis in chil-dren. J Pediatr. 1992;120:839–55.
  • McSherry G, Connor E. Current epidemiology of tuberculosis. Pediatr Ann. 1993;22:600–4.
  • Schutze GE, Jacobs RF. Treatment of tuberculous infection and disease. Pediatr Ann. 1993;22:631–9.
  • Brailey M. Mortality in tuberculin-positive infants. Bull Johns Hopkins Hosp. 1936;59:1–10.
  • Brailey ME. Tuberculosis in White and Negro Children II. The Epidemiologic Aspects of the Harriet Lane Study. Cambridge: Harvard University Press, 1958.
  • McAnulty JM, Fleming DW, Hawley MA, Baron RC. Missed op-portunities for tuberculosis prevention. Arch Intern Med. 1995; 155:713–6.
  • Comstock GW, Woolpert SF. Preventive therapy. In: Kubica GP, Wayne LG (eds). The Mycobacteria: A Source Book. New York: Marcel Dekker, 1984, pp 1071–81.
  • Moulding T. Preventive treatment of tuberculosis: a clinician's perspective. In: Rossman MD, MacGregor RR (eds). Tuberculo-sis Clinical Management and New Challenges. New York: Mc-Graw-Hill, 1995, pp 89–105.
  • International Union against Tuberculosis, Committee on Pro-phylaxis. Efficacy of various durations of isoniazid preventative therapy for tubercuiosis: five years of follow-up in the JUAT trial. Bull WHO. 1982;60:555–64.
  • Stead WW, Teresa T, Harrison RW, et at. Benefit-risk considera-tions in preventive treatment for tuberculosis in elderly persons. Ann Intern Med. 1987;107:843–5.
  • Snider DE Jr, Caras GJ, Koplan JP. Preventive therapy with isoni-azid: cost-effectiveness of different durations of therapy. JAMA. 1986;255:1579–83.
  • Barnes PF, Yang Z, Preston-Martin S, et at. Patterns of tuberculo-sis transmission in central Los Angeles. JAMA. 1997;278:1159–63.
  • Centers for Disease Control. Prevention and control of tuberculo-sis among homeless persons: recommendations of the Advisory Council for the Elimination of Tuberculosis. MMWR. 1992;41(RR-5):13–23.
  • Centers for Disease Control. Drug-resistant tuberculosis among the homeless-Boston. MMWR. 1985;34:735–6.
  • Barry MA, Wall C, Shirley L, et al. Tuberculosis screening in Boston's homeless shelters. Public Health Rep. 1986;101:487–94.
  • Slutkin G. Management of tuberculosis in urban homeless indi-gents. Public Health Rep. 1996;101:481–6.
  • McAdam J, Brickner PW, Glicksman R, Edwards D, Fallon B, Yanowitch P. Tuberculosis in the SRO/homeless population. In: Brickner PW, Scharer LW, Conanan B, Elvy A, Savarese M (eds). Health Care of Homeless People. New York: Springer, 1985.
  • Personal communication, Susan Joan Sink, Program Director, American Lung Association of Philadelphia and Montgomery Counties, 1998.
  • Adler R, Nunn R, Northam E. Secondary prevention of child-hood firesetting. J Am Acad Child Adolesc Psychiatry. 1994;33: 1194–202.
  • Hammond J, Varas R. Coordinated strategies in burn prevention programs: a case study. J Burn Care Rehabil. 1990;11:376–8.
  • Committee on Infectious Diseases. Screening for tuberculosis in infants and children. Pediatrics. 1994;93:131–4.
  • American Academy of Pediatrics. Tuberculosis. In: Peter G (ed). 1994 Red Book. Report of the Committee on Infectious Diseases, 23rd ed. Elk Grove Village, IL: American Academy of Pediatrics, 1994, pp 480–500.
  • Starke JR. Childhood tuberculosis during the 1990s. Pediatr Rev. 1992;13:343–53.
  • Starke JR. The tuberculin skin test. Pediatr Ann. 1993;22:612–20.
  • Howard TR, Solomon DA. Reading the tuberculin skin test. Who, when, and how? Arch Intern Med. 1988;148:2457–9.
  • Cheng TL, Ottolini M, Getson P, Wolf MD, Scheidt PC. Poor va-lidity of parent reading of skin test induration in a high risk pop-ulation. Pediatr Infect Dis J. 1996;15:90–2.
  • Serwint JR, Hall BS, Baldwin RM, Virden JM. Outcomes of an-nual tuberculosis screening by Mantoux test in children consid-ered to be at high risk: results from one urban clinic. Pediatrics. 1997;99:529–33.
  • Maqbool S, Asnes RS, Grebin B. Tine test compliance in a clinic setting. Pediatrics. 1975;55:388–91.
  • Snider DE, Hutton MD. Improving patient compliance in tuber-culosis treatment programs. Atlanta: Centers for Disease Con-trol, 1989.
  • American Lung Association of South Carolina. 1989 South Car-olina Tuberculosis Report. Columbia, SC: American Lung Asso-ciation of South Carolina, 1989.
  • Snider DE Jr, Anders HM, Pozsik CJ. Incentives to take up health services. Lancet. 1986;ii:812.
  • Christy C, Pulcino ML, Lamphear BP, McConnochie KM. Screen-ing for tuberculosis infection in urban children. Arch Pediatr Adolesc Med. 1996;150:722–6.
  • Sawert H, Kongsin S, Payanandana V, et al. Costs and benefits of improving tuberculosis control: the case of Thailand. Soc Sci Med. 1997;44:1805–16.
  • Rosenblum LS, Castro KG, Dooley S, et al. Effect of HIV infection and tuberculosis on hospitalizations and cost of care for young adults in the United States, 1985 to 1990. Ann Intern Med. 1994;121:786–92.
  • Shulkin DJ, Brennan PJ. The cost of caring for patients with tu-berculosis: planning for a disease on the rise. Am J Infect Con-trol. 1995;23:1–4.
  • Iseman MD, Cohn DL, Sbarbaro JA. Directly observed treatment of tuberculosis. We can't afford not to try it. N Engl J Med. 1993;328:576–8.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.